|
[1]
|
Baldwin KJ, Correll CM. Prion disease. Semin Neurol 2019;39(4):428 − 39. http://dx.doi.org/10.1055/s-0039-1687841CrossRef
|
|
[2]
|
Ironside JW, Ritchie DL, Head MW. Prion diseases. Handb Clin Neurol 2018;145:393 − 403. http://dx.doi.org/10.1016/B978-0-12-802395-2.00028-6CrossRef
|
|
[3]
|
Chen C, Dong XP. Epidemiological characteristics of human prion diseases. Infect Dis Poverty 2016;5(1):47. http://dx.doi.org/10.1186/s40249-016-0143-8CrossRef
|
|
[4]
|
Kim MO, Takada LT, Wong K, Forner SA, Geschwind MD. Genetic PrP prion diseases. Cold Spring Harb Perspect Biol 2018;10(5):a033134. http://dx.doi.org/10.1101/cshperspect.a033134CrossRef
|
|
[5]
|
Vallabh SM, Minikel EV, Williams VJ, Carlyle BC, McManus AJ, Wennick CD, et al. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease. BMC Med 2020;18(1):140. http://dx.doi.org/10.1186/s12916-020-01608-8CrossRef
|
|
[6]
|
Shi Q, Gao C, Zhou W, Zhang BY, Chen JM, Tian C, et al. Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007. BMC Public Health 2008;8:360. http://dx.doi.org/10.1186/1471-2458-8-360CrossRef
|
|
[7]
|
Gao C, Shi Q, Tian C, Chen C, Han J, Zhou W, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One 2011;6(8):e24231. http://dx.doi.org/10.1371/journal.pone.0024231CrossRef
|
|
[8]
|
Shi Q, Zhou W, Chen C, Zhang BY, Xiao K, Zhang XC, et al. The features of genetic prion diseases based on Chinese surveillance program. PLoS One 2015;10(10):e0139552. http://dx.doi.org/10.1371/journal.pone.0139552CrossRef
|
|
[9]
|
Shi Q, Chen C, Zhou W, Gao C, Xiao K, Zhang J, et al. The characteristics of Chinese prion diseases based on 10 years surveillance data from 2006 to 2015. Neuropsychiatry (London) 2018;8(3):739 − 44. http://dx.doi.org/10.4172/Neuropsychiatry.1000550CrossRef
|
|
[10]
|
Shi Q, Chen C, Xiao K, Zhou W, Gao C, Gao LP, et al. Characteristics of different types of prion diseases - China’s surveillance. China CDC Wkly 2022;4(33):723 − 8. http://dx.doi.org/10.46234/ccdcw2022.151CrossRef
|
|
[11]
|
Shi Q, Zhang XC, Zhou W, Xiao K, Chen C, Zhang HY, et al. Analysis of the advantage features of Beijing surveillance network for Creutzfeldt-Jakob disease. Prion 2015;9(4):304 − 14. http://dx.doi.org/10.1080/19336896.2015.1075115CrossRef
|
|
[12]
|
Manix M, Kalakoti P, Henry M, Thakur J, Menger R, Guthikonda B, et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus 2015;39(5):E2. http://dx.doi.org/10.3171/2015.8.FOCUS15328CrossRef
|
|
[13]
|
Maddox RA, Person MK, Blevins JE, Abrams JY, Appleby BS, Schonberger LB, et al. Prion disease incidence in the United States: 2003-2015. Neurology 2020;94(2):e153 − 7. http://dx.doi.org/10.1212/WNL.0000000000008680CrossRef
|
|
[14]
|
Zerr I, Parchi P. Sporadic Creutzfeldt-Jakob disease. Handb Clin Neurol 2018;153:155 − 74. http://dx.doi.org/10.1016/B978-0-444-63945-5.00009-XCrossRef
|
|
[15]
|
Newey CR, Sarwal A, Wisco D, Alam S, Lederman RJ. Variability in diagnosing Creutzfeldt-Jakob disease using standard and proposed diagnostic criteria. J Neuroimaging 2013;23(1):58 − 63. http://dx.doi.org/10.1111/j.1552-6569.2012.00763.xCrossRef
|